Selles J, Boland R
Departamento de Biologia, Universidad Nacional del Sur, Bahia Blanca, Argentina.
Mol Cell Endocrinol. 1991 May;77(1-3):67-73. doi: 10.1016/0303-7207(91)90059-2.
1,25-Dihydroxyvitamin D3 has been shown to induce rapid changes in calcium fluxes in skeletal muscle and other target tissues independently of gene activation. The possibility that the hormone would produce similar effects in heart where 1,25-dihydroxyvitamin D3 receptors and activities have been shown, was studied. A significant increase of 45Ca uptake by left ventricular slices from vitamin D-deficient chicks was observed upon incubation for 1-10 min with physiological doses of 1,25-dihydroxyvitamin D3. This stimulation was dose-dependent and specific for the hormone when compared with vitamin D3, 25-hydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 and could not be associated to changes in lipid synthesis as assessed by measurements of [3H]glycerol incorporation into cardiac tissue lipids. The Ca channel blockers nifedipine (30 microM) and verapamil (10 microM) abolished the increase in Ca uptake produced by 1,25-dihydroxyvitamin D3. The rapid effects of the hormone on heart Ca influx were accompanied by a stimulation of the phosphorylation of two microsomal proteins of 43 kDa and 55 kDa. These results further support a direct action of 1,25-dihydroxyvitamin D3 in the regulation of cardiac muscle Ca metabolism which may involve activation of Ca channels.
1,25 - 二羟基维生素D3已被证明可在骨骼肌和其他靶组织中独立于基因激活而诱导钙通量的快速变化。研究了该激素在心脏中是否会产生类似作用,心脏中已发现存在1,25 - 二羟基维生素D3受体和相关活性。用生理剂量的1,25 - 二羟基维生素D3孵育1 - 10分钟后,观察到维生素D缺乏雏鸡左心室切片对45Ca的摄取显著增加。与维生素D3、25 - 羟基维生素D3和24,25 - 二羟基维生素D3相比,这种刺激具有剂量依赖性且对该激素具有特异性,并且通过测量[3H]甘油掺入心脏组织脂质来评估,其与脂质合成的变化无关。钙通道阻滞剂硝苯地平(30 microM)和维拉帕米(10 microM)消除了1,25 - 二羟基维生素D3引起的钙摄取增加。该激素对心脏钙内流的快速作用伴随着对两种43 kDa和55 kDa微粒体蛋白磷酸化的刺激。这些结果进一步支持了1,25 - 二羟基维生素D3在调节心肌钙代谢中具有直接作用,这可能涉及钙通道的激活。